IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-019-12733-1.html
   My bibliography  Save this article

A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease

Author

Listed:
  • Qi Sun

    (New York University, School of Medicine
    New York University, School of Medicine)

  • Wendy Lee

    (New York University, School of Medicine
    New York University, School of Medicine)

  • Yasuaki Mohri

    (Tokyo Medical and Dental University)

  • Makoto Takeo

    (New York University, School of Medicine
    New York University, School of Medicine)

  • Chae Ho Lim

    (New York University, School of Medicine
    New York University, School of Medicine)

  • Xiaowei Xu

    (Hospital of the University of Pennsylvania)

  • Peggy Myung

    (Yale Cancer Center, Yale School of Medicine)

  • Radhika P. Atit

    (Case Western Reserve University)

  • M. Mark Taketo

    (Kyoto University)

  • Rana S. Moubarak

    (New York University, School of Medicine)

  • Markus Schober

    (New York University, School of Medicine
    New York University, School of Medicine)

  • Iman Osman

    (New York University, School of Medicine)

  • Denise L. Gay

    (Inserm UMR_967, CEA/DRF/IBFJ/iRCM/LRTS)

  • Dieter Saur

    (German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
    School of Medicine, Klinikum rechts der Isar, Technische Universität München)

  • Emi K. Nishimura

    (Tokyo Medical and Dental University)

  • Mayumi Ito

    (New York University, School of Medicine
    New York University, School of Medicine)

Abstract

Melanoma, the deadliest skin cancer, remains largely incurable at advanced stages. Currently, there is a lack of animal models that resemble human melanoma initiation and progression. Recent studies using a Tyr-CreER driven mouse model have drawn contradictory conclusions about the potential of melanocyte stem cells (McSCs) to form melanoma. Here, we employ a c-Kit-CreER-driven model that specifically targets McSCs to show that oncogenic McSCs are a bona fide source of melanoma that expand in the niche, and then establish epidermal melanomas that invade into the underlying dermis. Further, normal Wnt and Endothelin niche signals during hair anagen onset are hijacked to promote McSC malignant transformation during melanoma induction. Finally, molecular profiling reveals strong resemblance of murine McSC-derived melanoma to human melanoma in heterogeneity and gene signatures. These findings provide experimental validation of the human melanoma progression model and key insights into the transformation and heterogeneity of McSC-derived melanoma.

Suggested Citation

  • Qi Sun & Wendy Lee & Yasuaki Mohri & Makoto Takeo & Chae Ho Lim & Xiaowei Xu & Peggy Myung & Radhika P. Atit & M. Mark Taketo & Rana S. Moubarak & Markus Schober & Iman Osman & Denise L. Gay & Dieter , 2019. "A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease," Nature Communications, Nature, vol. 10(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12733-1
    DOI: 10.1038/s41467-019-12733-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-12733-1
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-019-12733-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Veronica Davalos & Claudia D. Lovell & Richard Itter & Igor Dolgalev & Praveen Agrawal & Gillian Baptiste & David J. Kahler & Elena Sokolova & Sebastian Moran & Laia Piqué & Eleazar Vega-Saenz de Mier, 2023. "An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma," Nature Communications, Nature, vol. 14(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12733-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.